| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| STAAR SURGICAL CO | 10%+ Owner | Common Stock | 15,453,629 | $356,824,293 | $23.09 | 09 Jan 2026 | Indirect |
| STAAR SURGICAL CO | 10%+ Owner | Common Stock | 15,453,629 | $340,805,061 | $22.05 | 09 Jan 2026 | Direct |
| Insight Molecular Diagnostics Inc. | 10%+ Owner | Common Stock, no par value | 11,931,839 | $89,488,792 | $7.50 | 10 Feb 2026 | Indirect |
| Insight Molecular Diagnostics Inc. | 10%+ Owner | Common Stock, no par value | 11,931,839 | $68,608,074 | $5.75 | 10 Feb 2026 | Direct |
| Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Shares | 49,560,992 | $37,666,354 | $0.7600 | 27 Jan 2025 | Direct |
| Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Shares | 49,560,992 | $37,666,354 | $0.7600 | 27 Jan 2025 | Indirect |
| Insight Molecular Diagnostics Inc. | 10%+ Owner | Warrant to Purchase Common Stock | 150,093 | $1,125,697 | $7.50 | 10 Feb 2026 | Direct |
| Insight Molecular Diagnostics Inc. | 10%+ Owner | Warrant to Purchase Common Stock | 150,093 | $1,125,697 | $7.50 | 10 Feb 2026 | Indirect |
| Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Warrant | 7,894,737 | 27 Jan 2025 | Direct | ||
| Lineage Cell Therapeutics, Inc. | Director, 10%+ Owner | Common Warrant | 7,894,737 | 27 Jan 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IMDX | Insight Molecular Diagnostics Inc. | 10 Feb 2026 | 2 | +$2,999,999 | 4 | 10%+ Owner | 12 Feb 2026, 19:49 |
| STAA | STAAR SURGICAL CO | 09 Jan 2026 | 2 | +$606,138 | 4 | 10%+ Owner | 13 Jan 2026, 21:30 |
| STAA | STAAR SURGICAL CO | 06 Jan 2026 | 8 | +$8,817,664 | 4 | 10%+ Owner | 08 Jan 2026, 19:31 |
| STAA | STAAR SURGICAL CO | 19 Nov 2025 | 6 | +$41,060,317 | 4 | 10%+ Owner | 21 Nov 2025, 21:55 |
| STAA | STAAR SURGICAL CO | 08 Apr 2025 | 8 | +$2,866,428 | 4 | 10%+ Owner | 10 Apr 2025, 19:00 |
| STAA | STAAR SURGICAL CO | 03 Apr 2025 | 10 | +$13,627,504 | 4 | 10%+ Owner | 07 Apr 2025, 20:28 |
| STAA | STAAR SURGICAL CO | 31 Mar 2025 | 4 | +$941,285 | 4 | 10%+ Owner | 02 Apr 2025, 20:33 |
| STAA | STAAR SURGICAL CO | 26 Mar 2025 | 6 | +$1,983,824 | 4 | 10%+ Owner | 28 Mar 2025, 18:45 |
| STAA | STAAR SURGICAL CO | 21 Mar 2025 | 4 | +$2,414,722 | 4 | 10%+ Owner | 25 Mar 2025, 19:02 |
| STAA | STAAR SURGICAL CO | 18 Mar 2025 | 6 | +$3,586,283 | 4 | 10%+ Owner | 20 Mar 2025, 19:51 |
| STAA | STAAR SURGICAL CO | 04 Mar 2025 | 4 | +$481,849 | 4 | 10%+ Owner | 06 Mar 2025, 19:07 |
| STAA | STAAR SURGICAL CO | 27 Feb 2025 | 12 | +$11,275,555 | 4 | 10%+ Owner | 03 Mar 2025, 19:12 |
| STAA | STAAR SURGICAL CO | 12 Feb 2025 | 10 | +$6,274,767 | 4 | 10%+ Owner | 14 Feb 2025, 19:00 |
| OCX | Oncocyte Corp | 06 Feb 2025 | 4 | +$10,589,675 | 4 | 10%+ Owner | 10 Feb 2025, 20:43 |
| LCTX | Lineage Cell Therapeutics, Inc. | 27 Jan 2025 | 4 | +$6,000,000 | 4 | Director, 10%+ Owner | 28 Jan 2025, 19:49 |
| STAA | STAAR SURGICAL CO | 14 Jan 2025 | 4 | +$630,839 | 4 | 10%+ Owner | 16 Jan 2025, 19:20 |
| STAA | STAAR SURGICAL CO | 16 Dec 2024 | 8 | +$1,947,540 | 4 | 10%+ Owner | 18 Dec 2024, 19:00 |
| OCX | Oncocyte Corp | 02 Oct 2024 | 2 | +$3,877,619 | 4 | 10%+ Owner | 04 Oct 2024, 19:00 |
| STAA | STAAR SURGICAL CO | 09 May 2024 | 2 | +$42.56 | 4 | 10%+ Owner | 13 May 2024, 18:00 |
| OCX | Oncocyte Corp | 11 Apr 2024 | 4 | +$7,057,688 | 4 | 10%+ Owner | 15 Apr 2024, 19:21 |
| LCTX | Lineage Cell Therapeutics, Inc. | 06 Feb 2024 | 2 | +$7,000,001 | 4 | Director, 10%+ Owner | 08 Feb 2024, 18:58 |
| STAA | STAAR SURGICAL CO | 08 Jan 2024 | 2 | +$109,570 | 4 | 10%+ Owner | 10 Jan 2024, 17:44 |
| STAA | STAAR SURGICAL CO | 03 Jan 2024 | 8 | +$6,481,557 | 4 | 10%+ Owner | 05 Jan 2024, 19:07 |
| STAA | STAAR SURGICAL CO | 28 Nov 2023 | 10 | +$13,703,831 | 4 | 10%+ Owner | 30 Nov 2023, 19:08 |
| STAA | STAAR SURGICAL CO | 10 Nov 2023 | 4 | +$1,140,132 | 4 | 10%+ Owner | 14 Nov 2023, 19:13 |
| STAA | STAAR SURGICAL CO | 07 Nov 2023 | 8 | +$9,662,782 | 4 | 10%+ Owner | 09 Nov 2023, 19:01 |
| STAA | STAAR SURGICAL CO | 02 Nov 2023 | 8 | +$10,797,514 | 4 | 10%+ Owner | 06 Nov 2023, 19:01 |
| STAA | STAAR SURGICAL CO | 04 Oct 2023 | 6 | +$7,762,466 | 4 | 10%+ Owner | 06 Oct 2023, 19:43 |
| STAA | STAAR SURGICAL CO | 19 Sep 2023 | 6 | +$11,689,354 | 4 | 10%+ Owner | 21 Sep 2023, 20:31 |
| STAA | STAAR SURGICAL CO | 05 Sep 2023 | 6 | +$7,868,913 | 4 | 10%+ Owner | 07 Sep 2023, 19:00 |
| OCX | Oncocyte Corp | 03 Apr 2023 | 2 | +$8,093,898 | 4 | 10%+ Owner | 05 Apr 2023, 21:35 |
| STAA | STAAR SURGICAL CO | 27 Dec 2022 | 6 | +$9,061,575 | 4 | 10%+ Owner | 29 Dec 2022, 17:26 |
| OCX | Oncocyte Corp | 13 Apr 2022 | 6 | +$8,000,000 | 4 | 10%+ Owner | 15 Apr 2022, 18:13 |
| LCTX | Lineage Cell Therapeutics, Inc. | 23 Mar 2022 | 6 | +$1,317,667 | 4 | Director, 10%+ Owner | 25 Mar 2022, 17:56 |
| STAA | STAAR SURGICAL CO | 01 Oct 2021 | 2 | $0 | 4 | 10%+ Owner | 01 Oct 2021, 16:53 |
| OCX | Oncocyte Corp | 23 Sep 2021 | 8 | +$1,807,836 | 4 | 10%+ Owner | 24 Sep 2021, 16:56 |
| STAA | STAAR SURGICAL CO | 01 Jul 2021 | 2 | $0 | 4 | 10%+ Owner | 02 Jul 2021, 19:03 |
| STAA | STAAR SURGICAL CO | 24 Jun 2021 | 6 | -$35,650,796 | 4 | 10%+ Owner | 28 Jun 2021, 18:50 |
| STAA | STAAR SURGICAL CO | 16 Jun 2021 | 6 | -$16,168,382 | 4 | 10%+ Owner | 21 Jun 2021, 08:28 |
| STAA | STAAR SURGICAL CO | 11 Jun 2021 | 6 | -$8,787,536 | 4 | 10%+ Owner | 15 Jun 2021, 20:59 |
| STAA | STAAR SURGICAL CO | 27 May 2021 | 6 | -$39,065,521 | 4 | 10%+ Owner | 01 Jun 2021, 19:21 |